SOUTH SAN FRANCISCO, Calif., May 22, 2024 Cytokinetics, Incorporated today announced the pricing of an underwritten public offering of 9,803,922 shares of its common stock at a price to the.
Cytokinetics Reports Fourth Quarter 2021 Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics Announces Pricing of Public Offering of Common Stock
July 20, 2021 23:15 ET | Source: Cytokinetics, Incorporated Cytokinetics, Incorporated South San Francisco, California, UNITED STATES
SOUTH SAN FRANCISCO, Calif., July 20, 2021 (GLOBE NEWSWIRE) Cytokinetics, Incorporated (Nasdaq:CYTK) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $27.50 per share, before underwriting discounts and commissions. The gross proceeds to Cytokinetics from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Cytokinetics, are expected to be $275 million. The offering is expected to close on July 23, 2021, subject to customary closing conditions. Additionally, Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock at the publi